Moreover, the frequencies of aN and dnCS B cells positively correlated with biomarkers of IL‐6 and CRP concentrations (Figure 1C), suggesting the association of aN and dnCS B cells expansion with COVID‐19 severity. The gene discussed is CRP; the disease is COVID-19.